* Aequus Pharmaceuticals Inc - received positive feedback from FDA to pursue abbreviated 505(b)(2) clinical pathway for co's AQS1301 Sign up here. * Aequus Pharmaceuticals- upon review of pre-IND ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results